Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Block for Postoperative Analgesia in Secondary Total Hip Arthroplasty; (REVPET)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire Vaudois

About this trial

The aim of this clinical trial is to compare the analgesic effect of a pericapsular nerve group (PENG) block with a combined femoral, sciatic, lateral femoral cutaneous nerve block for postoperative analgesia in patients scheduled for secondary total hip arthroplasty. The primary objective of this study is to compare postoperative pain management between the PENG block and the combined block (femoral, sciatic, lateral femoral cutaneous) by measuring postoperative morphine consumption in each of the two groups.

Participants will be randomized into two groups. Patients assigned to the PENG group will receive a PENG block with ropivacaine, followed by a sham (sciatic) block, and spinal anesthesia with isobaric bupivacaine. Patients assigned to the combined block group will receive femoral, sciatic, lateral femoral cutaneous nerve blocks with ropivacaine, followed by spinal anesthesia with isobaric bupivacaine.

Eligibility criteria

Qualifiers

Male and female patients

ASA (American Society of Anaesthesiologists) I-III

18 years of age or older

Patients scheduled for elective secundary hip arthroplasty

Disqualifiers

Refusal or inability to give consent

Allergy to any of: ropivacaine, paracetamol, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone

Bleeding diathesis

Neurological deficit of the operative side

Trial design

Treatments tested in this trial

  • Pericapsular nerve group (PENG) block with 0.75% ropivacaine guided by ultrasound
  • Femoral, sciatic and lateral femoral cutaneous nerve block with 0.375% ropivacaine

Treatment groups

50 Participants
are divided into 2 treatment groups

Locations

This trial has no locations